🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Hong Kong-based startup Great Bay Bio secures $15M funding
Contract Manufacturing | News | 0 Comment | 15 Sep, 2022
Great Bay Bio (GBB), Hong Kong-based startup, has announced the completion of its $15 million Pre-series B funding ...Read more
Catalent invests $2.2M for Singapore clinical supply facility expansion
Contract Manufacturing | News | 0 Comment | 07 Sep, 2022
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, lau...Read more
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...Read more
WuXi Biologics opens first North American biomanufacturing facility in New Jersey
Contract Manufacturing | News | 0 Comment | 01 Sep, 2022
China's WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has anno...Read more
WuXi announces licensing agreement with Janssen for TESSA technology
Contract Manufacturing | News | 0 Comment | 12 Aug, 2022
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...Read more
BioDuro-Sundia and X-Chem focus on new small molecule drug discovery in China
Contract Manufacturing | News | 0 Comment | 08 Aug, 2022
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...Read more
How CDMOs are Adapting to New mRNA Tech Demands
Contract Manufacturing | Opinion | By Ayesha Siddiqui | 0 Comment | 30 Jul, 2022
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...Read more
WuXi Biologics invests $1.4 B to build comprehensive CRDMO centre in Singapore
Contract Manufacturing | News | 0 Comment | 19 Jul, 2022
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...Read more
Samsung Biologics further invests KRW 426 B for Bio Campus 2
Contract Manufacturing | News | 0 Comment | 18 Jul, 2022
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...Read more
TFBS Biosciences expands state-of-the-art facility for viral vector production in Taiwan
Contract Manufacturing | News | 0 Comment | 15 Jul, 2022
TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...Read more
GenScript ProBio partners with DAAN Bio Therapeutics for novel drug discovery
Contract Manufacturing | News | 0 Comment | 14 Jul, 2022
GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...Read more
Amaran Biotech introduces first fully-automated robotic aseptic filling line in Taiwan
Contract Manufacturing | News | 0 Comment | 13 Jul, 2022
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., has completed the construction of it...Read more
WuXi STA opens new large-scale oligonucleotide and peptide manufacturing facility
Contract Manufacturing | News | 0 Comment | 07 Jul, 2022
WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...Read more
Vetter’s newest clinical manufacturing site successfully completed its first customer fills
Contract Manufacturing | News | 0 Comment | 04 Jul, 2022
Next milestone for the site development is achieved Positive feedback recei...Read more
Fujifilm invests $1.6 B to expand global offering of cell culture manufacturing services
Contract Manufacturing | News | 0 Comment | 04 Jul, 2022
Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...Read more
WuXi STA opens another high-potency API plant in China
Contract Manufacturing | News | 0 Comment | 01 Jul, 2022
WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...Read more
How Is BioManufacturing Driving APAC CDMO Market?
Contract Manufacturing | Analysis | By Hithaishi C Bhaskar | 0 Comment | 30 Jun, 2022
Companies in the pharmaceutical sector have been facing fierce competition, cost pressure, technological innovations, an...Read more
Eurofins DiscoverX expands APAC operations with new biotech office in China
Contract Manufacturing | News | 0 Comment | 04 Jul, 2022
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...Read more